
P&G goes shopping, and the cart got expensive
Procter & Gamble just agreed to buy science-backed health and wellness brand Thorne from L Catterton for $3.8 billion in cash. That’s not pocket change — that’s “we really want this shelf space” money.
Why this matters
For P&G, this looks like a classic growth-and-diversification play: add a wellness brand with a science-forward halo, then try to scale it inside a much bigger consumer engine. For investors, the question is less “did they buy something?” and more “can they turn a premium brand into a bigger profit stream without sanding off the thing that made it special?”
The bigger picture
M&A in consumer land usually comes down to one simple game: buy a brand people trust, distribute it everywhere, and hope the math works out better than your latest streaming subscription. If P&G can make Thorne feel both premium and mainstream, this could be a tidy bolt-on. If not, it’s just a very expensive trophy on the shelf.
Big picture: P&G is betting that wellness is still one of the few corners of consumer spending where people will happily pay extra for a better story.
